Things continue to fall into place for a sale of the company by the end of the year. I predict that once the GSK PentaStaph deal closes and the company pockets the first installment of $26mil. that the company will annouce the sale. Since announcement of the the GSK deal NABI potential has increased with the NH $10mil grant, commencement of phase 3 for NicVax and commencement of the phase 2B test to determine is the drug can prevent relapse after a smoker has quit with the aid of another drug.